Why is the evidence on capsule endoscopy sensitivity for detecting submucosal small bowel lesions inconsistent across studies
What is known
- Capsule endoscopy visualizes the mucosal surface only and cannot obtain tissue biopsies, so lesions must be interpreted with caution and confirmed histologically when a diagnosis is uncertain. 1
What is unknown / caveats
- The excerpts do not directly address capsule endoscopy's sensitivity for submucosal small bowel lesions. - They do not explain why such evidence would be inconsistent across studies.
## References
1. Singeap AM, Sfarti C, Girleanu I, Huiban L, Muzica C, Timofeiov S, Stanciu C, Trifan A. Reclassification of Inflammatory Bowel Disease Type Unclassified by Small Bowel Capsule Endoscopy. Medicina (Kaunas). 2023;59(12). PMID: 38138167.
For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.
⚠ Required context not in this corpus (severe). ESGE guideline (Pennazio 2015, PMID 25826168) for small-bowel capsule endoscopy and device-assisted enteroscopy, including assessment of small-bowel patency before capsule endoscopy where stricturing disease is known or suspected.
_Why this matters:_ Recommending capsule endoscopy without the patency step in suspected stricturing small-bowel disease risks a retained capsule and an avoidable retrieval procedure.
_Added by the landmark interlock. This corpus is surgical in scope and cannot admit the source paper (PMID 25826168). Not generated by the RAG._
---
_Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct._
Reviewer notes